Vacunas parasitarias: un recuento bibliográfico

Jesús Gregorio Rodríguez Diego, Javier Lorenzo Olivares Orozco

Resumen

Se realizó una recopilación bibliográfica en bases de datos informativas: Academic Search Complete (EBSCO), Scopus y Web de la Ciencia, desde el año 1965 hasta 2019, con el objetivo de recopilar las principales investigaciones realizadas con vistas a lograr inmunógenos contra los parásitos más importantes que afectan a humanos y animales. Se evidencian los avances obtenidos, fundamentalmente, en Plasmodium falciparum, Giardia lamblia, Leishmania spp., Toxoplasma gondii, Taenia solium, Schistosoma mansoni, Rhipicephalus microplus, entre otros agentes parásitos patógenos. Se concluye que la elaboración de vacunas contra parásitos resulta un gran reto y actualmente se enfoca en nuevos trabajos de biología molecular para seleccionar antígenos más eficaces, así como se consideran estrategias para buscar nuevos adyuvantes que favorezcan la orientación apropiada de la respuesta inmune.

Palabras clave

vacuna; Plasmodium falciparum; Giardia lamblia; Schistosoma mansoni; Leishmania; Rhipicephalus microplus

Texto completo:

PDF HTML XML EPUB

Referencias

Diambra L. Gene target discovery with network analysis in Toxoplasma gondii. Sci Reports. 2019;9(1):646.

Miller HRP. Respuesta inmunitaria contra el parasitismo interno Rev Sci Tech Off Int Epiz. 1990;9(1):331-344.

Cruz Chan JV, Rosado Vallado ME, Dumonteil E. Desarrollo de vacunas contra parásitos. Rev Ciencia. 2017;68(1):81-85.

Arredondo JL, Flores ME, Galán JF. Programa de actualización continua para el infectólogo. 1 ed. México. Editorial intersistemas S.A de C.V.1998.

Olson ME, Ceri H, Morck DW. Giardia Vaccination. Parasitology Today. 2000;16(5):213-217.

Delgado Chavarria IV. Evaluación de la efectividad de la vacuna Giardia Vax en cachorros de Canis domesticus. Tesis para optar por el título de: Licenciada en Medicina Veterinaria y Zootecnia 2007; San Salvador.

Kuttler KL. Comparative efficacy of different immunization systems against anaplasmosis. Trop Anim Health and Prod. 1971;3 (2):77-82.

Kuttler KL. Comparative response to premunization using attenuated Anaplasma marginale, virulent A. marginale and A. centrale in different age groups. Trop Animal Health and Product. 1972;4(4):197-203.

Targett GAT, Fulton JD. Immunization of rhesus monkeys against Plasmodium knowlesi malaria. Exp Parasit. 1965;17(2)180-193.

Zuckerman A, Hamburger J, Spira D. Active immunization of rats with a cell-free extract of the erythrocytic parasites of Plasmodium berghei. Exp Parasit. 1967;21(1):84-97.

Nakayama I. Effects of immunization procedures in experimental toxoplasmosis. The Keio J Med. 1965;14(2):63-72.

Pirie HM, Jarrett W H, Crighton GW.Studies on vaccination against East Coast fever using macroschizonts. Exp Parasit. 1970;27(3):343-349.

Löhr KF. Immunity to Babesia bigemina in Experimentally Infected Cattle.The J Protozool. 197219(4):658-660.

Ali NA, Binnerts W , Klimes B.Immunization by Irradiated Eimeria acervulina. The J Protozool. 1972;19(1):177-180.

Gómez E, Rodríguez Diego J G. Desarrollo de una vacuna contra la coccidiosis aviar . Resultados de la Ciencia en Cuba - Premios resultados.redciencia.cu > premios > n_acc > resumen 1995. (consultado 18/10/2019).

Wikerhauser T, Žuković M, Džakula N. Taenia saginata and T. hydatigena: Intramuscular vaccination of calves with oncospheres. Exp Parasit. 1971;30(1):36-40.

Miller TA. Pathogenesis and immunity in hookworm infection. Transactions of the Royal Soc of Trop Med and Hyg. 1968;62(4):473-489.

Casarosa L, Macchioni G, Marconcini A.Vaccination against Dictyocaulus filaria in sheep with oral administration of 3rd stage larvae irradiated with Co60. Experimental studies with 45-day-old lambs. Arch Vet italiano. 1968;19(5):321-336.

Sukarsih H, Partoutomo S, Satria E, Wijffels G, Riding G, Eisemann C, et al Vaccination against the Old World screwworm fly (Chrysomya bezziana). Parasite Immun. 2000;22(11):545-552.

Serradell MC, Rupil LL, Martino RA, Prucca CG, Carranza PG, Saura A, et al.Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins. Nature Communications 2019;10(1):361.

Stager S, Smith DF, Kaye PM. Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis. J Immun 2000; 165 (12): 7064-7071.

Chapman HD. Practical use of vaccines for the control of coccidiosis in the chicken. World's Poultry Sci J. 2014;56(1):18-20.

Tomazic M L, Rodriguez A E, Lombardelli J, Poklepovich T, Garro C, Galarza R, et al. Identification of novel vaccine candidates against cryptosporidiosis of neonatal bovines by reverse vaccinology. Vet Parasit. 2018;264:74-78.

Reiling L, Boyle M J, White M T, Wilson D W, Feng G, Weaver R, et al. Targets of complement-fixing antibodies in protective immunity against malaria in children. Nature Comm 2019;10(1):610.

Durojaye OA, Joshua PE, Cosmas S, Njoku UO, Okagu IU, Difa AC, et al. A reverse vaccinology approach in the identification of potential vaccine candidates from Plasmodium falciparum erythrocyte membrane protein. Pharmacology. 2018;3:23-36.

Nagaoka H, Sasaoka C, Yuguchi T, Kanoi BN, Ito D, Morita M, et al.PfMSA180 is a novel Plasmodium falciparum vaccine antigen that interacts with human erythrocyte integrin associated protein (CD47). Sci Reports. 2019;9(1):5923.

Douglas AD, Baldeviano GC, Jin J, Miura K, Diouf A, Zenonos ZA, et al. A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates. Nature Comm. 2019;10 (1):1953.

Durojaye OA, Joshua E, Cosmas S, Njoku UO, Okagu IU, Difa AC, et al. A reverse vaccinology approach in the identification of potential vaccine candidates from Plasmodium falciparum erythrocyte membrane protein 1. Pharmacology. 2018;3(30):23-36.

Portillo S, Zepeda BG, Iniguez E, Olivas J J, Karimi NH, Moreira OC, et al. A prophylactic α-Gal-based glycovaccine effectively protects against murine acute Chagas disease. Vaccines. 2019;4(1):13.

Ramakrishnan C, Maier S, Walker RA, Rehrauer H, Joekel DE, Winiger RR, et al. An experimental genetically attenuated live vaccine to prevent transmission of Toxoplasma gondii by cats. Sci Reports. 2019;9(1):1474.

Zouain CS, Gustavson S, Oliveira SC, Azevedo V, Alves JB, Goes AM. The role of IL-10 and IgG1 in the protection and granulomatous response in Schistosoma mansoni P24-immunized mice. Vaccine. 2000;19(9-10):1218-1224.

Martínez-Ortiz Ollero T, Nogal Ruiz JJ. Sm14/gla-se: primera vacuna frente a Schistosoma mansoni. Trabajo fin de Grado 2018. Facultad de Farmacia Universidad Complutense.

Organización Mundial de la Salud. Teniasis y cisticercosis 2018. https://www.who.int › ... › Centro de prensa › Notas descriptivas › Detail (consultado 10/10/2019).

Shey RA, Ghogomu SM, Esoh KK, Nebangwa ND, Shintouo M, Nongley NF, et al. In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases. Sci Reports. 2019;9(1):4409.

Ren HN, Guo KX, Zhang Y, Sun GG, Liu RD, Jiang P. Molecular characterization of a 31 kDa protein from Trichinella spiralis and its induced immune protection in BALB/c mice 11 Medical and Health Sciences 1107 Immunology. Parasites and Vectors. 2018;11(1):625.

Qi X, Han Y, Jiang P, Yue X, Ren HN, Sun GG. Oral vaccination with Trichinella spiralis DNase II DNA vaccine delivered by attenuated Salmonella induces a protective immunity in BALB/c mice. Vet Res. 2018;49(1):119.

Zhang N, Li W, Fu B. Vaccines against Trichinella spiralis: Progress, challenges and future prospects.Transboundary and Emerging Dis. 2018;65(6):1447-1458.

Importantes avances para la obtención de una vacuna contra la ‘Fasciola hepatica’ en ovino. www.oviespana.com › servicio-diario-de-noticias › en-portada › impo.(consultado 10/10/2019).

Kesik-Brodacka M, Lipiec A, Kozak LM, Jedlina L, Miedzinska K, Mikolajczak M, et al. Immune response of rats vaccinated orally with various plant-expressed recombinant cysteine proteinase constructs when challenged with Fasciola hepatica metacercariae. PLoS Neglected Trop Dis. 2017;11(3):1-18.

Rasouli A, Farahnak Ali, Zali H, Rezaeian M, Golestani A, Molaei R, Mohammad B. Protein Detection of Excretory-Secretory Products and Somatic Extracts from Fasciola hepatica and F. gigantica Using Two-Dimensional Electrophoresis. Iranian J Parasitol. 2019;14 (3):379-386.

González-Sánchez ME, Ndombasi-Bokuy M, Cuquerella M, Alunda JM. Immunization with recombinant rHc23 partially protects lambs against trickle infections byHaemonchus contortus. BMC Vet Res. 2019;15:333.

Sequeira JF. Prueba de campo de Gavac: vacuna contra garrapatas Rhipicephalus microplus. Bol Parasit. 2014;15(1):ISSN 1659-0295.

Murray PK. Molecular vaccines against animal parasites. Vaccine. 1989;7:291-299.

Calamante G. Desarrollo de vacunas de nueva generación Desarrollo de vacunas de nueva generación http://ria.inta.gob.ar/contenido/desarrollo-de-vacunas-de-nueva-generacion-para-uso-veterinario?l=es 2018 (consultado 10/10/2019).

Volz A, Sutter G. Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development Adv Virus Res. 2017;97:187-243.

Enlaces refback

  • No hay ningún enlace refback.